文献速递主动脉外科

胸主动脉腔内修复术覆盖左锁骨下动脉后的结局

Outcomes After Thoracic Endovascular Aortic Repair With Overstenting of the Left Subclavian Artery.
PubMed 文献 · Ann Thorac Surg · 2018-11-30

本研究回顾性分析176例TEVAR中完全覆盖左锁骨下动脉的患者,其中55例(31.3%)行血运重建,121例(68.7%)未行。未行血运重建是手术相关不良事件(左半球卒中、左臂灌注不良、永久性截瘫)的独立危险因素(OR 3.779,95%CI 1.096-13.029,p=0.035),建议行左锁骨下动脉血运重建。

要点

  • 未行LSA血运重建者左臂灌注不良发生率为9.9%(12/121)。
  • 未行LSA血运重建是手术相关不良事件的独立危险因素(OR 3.779)。
  • 使用≥2个覆膜支架和冠心病也是独立危险因素。

核心结论

  • 未行左锁骨下动脉血运重建、使用两个或以上覆膜支架及冠心病是TEVAR完全覆盖LSA后手术相关不良事件的独立危险因素。
  • 建议行LSA血运重建以预防左椎动脉相关中枢神经系统并发症并维持左上肢灌注。

研究设计与样本

  • 多中心回顾性研究,纳入2001年8月至2016年10月间176例(平均年龄61.3±15.8岁)接受TEVAR并完全覆盖LSA的患者。
  • 55例(31.3%)行LSA血运重建,121例(68.7%)未行;围手术期数据回顾性收集进行统计分析。

主要发现

  • 总体院内死亡率为8.5%(n=15),随访死亡率为9.1%(n=16),包括88例(50%)急诊或紧急病例。
  • 全队列卒中(不区分部位)发生率为6.8%,永久性截瘫发生率为6.3%。
  • 孤立性左上肢灌注不良仅发生于未行LSA血运重建的121例患者中的12例(9.9%)。
  • 未行LSA血运重建且左臂灌注不良者左半球卒中的发生率是其他患者的四倍(16.7% vs 3.7%,p=0.095)。

关键数值与推荐

  • 未行LSA血运重建:OR 3.779,95%CI 1.096-13.029,p=0.035(手术相关不良事件的独立危险因素)。
  • 使用两个或以上覆膜支架:OR 3.814,95%CI 1.557-9.343,p=0.003(独立危险因素)。
  • 冠心病:OR 3.276,95%CI 1.262-8.507,p=0.015(独立危险因素)。

临床怎么用

  • TEVAR需完全覆盖LSA时,应行LSA血运重建以降低左半球卒中、左臂灌注不良和永久性截瘫风险。
  • 应尽量使用单个覆膜支架以减少广泛主动脉覆盖,并评估患者冠心病情况。

局限性

  • 回顾性研究设计可能引入选择偏倚。
  • 原文未报告随访时长、具体统计方法等其他局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Our study aim was to evaluate the impact of left subclavian artery (LSA) flow preservation during thoracic endovascular aortic repair (TEVAR) on outcome. METHODS: Between August 2001 and October 2016, 176 patients (mean age, 61.3 ± 15.8 years) underwent TEVAR with complete LSA coverage. Fifty-five of those patients (31.3%) also underwent LSA revascularization, whereas 121 patients (68.7%) did not. Perioperative data were acquired retrospectively for statistical analysis at the three study institutions. RESULTS: Overall in-hospital and follow-up mortality was 8.5% (n = 15) and 9.1% (n = 16), respectively, including 88 urgent and emergent cases (50%). Stroke (independent of location) and permanent paraplegia rates were 6.8% and 6.3%, respectively, for the entire cohort. Isolated upper-left extremity malperfusion exclusively occurred in 12 (9.9%) of the 121 patients without LSA revascularization. Left-hemispheric stroke was observed four times more often in patients without LSA revascularization and left arm malperfusion (16.7% versus 3.7%, p = 0.095). Multivariate analysis identified no LSA revascularization (odds ratio [OR] 3.779, 95% confidence interval [CI]: 1.096 to 13.029, p = 0.035), two or more endografts (OR 3.814, 95% CI: 1.557 to 9.343, p = 0.003), and coronary artery disease (OR 3.276, 95% CI: 1.262 to 8.507, p = 0.015) as independent risk factors for procedure-related adverse events (left-hemispheric stroke, left arm malperfusion, and permanent paraplegia) after TEVAR with complete LSA overstenting. CONCLUSIONS: Every 10th patient with LSA overstenting and no revascularization experienced left arm malperfusion. No LSA revascularization, extensive aortic coverage with two or more endografts, and coronary artery disease increased the risk of permanent paraplegia, left-hemispheric stroke, and left arm malperfusion. Patients should undergo LSA revascularization to prevent left vertebral artery-associated central neurologic complications and to maintain upper-left extremity perfusion.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Luehr M, Etz CD, Berezowski M, et al. Outcomes After Thoracic Endovascular Aortic Repair With Overstenting of the Left Subclavian Artery. Ann Thorac Surg. 2018. PMID: 30508536. doi:10.1016/j.athoracsur.2018.10.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。